Skip to content

Comparison of Diaphragmatic Breathing and Muscle Relaxation for Rumination

Diaphragmatic Breathing and Progressive Muscle Relaxation: Behavioral Interventions for Gastrointestinal Rumination

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01576302
Enrollment
13
Registered
2012-04-12
Start date
2012-04-30
Completion date
2014-12-31
Last updated
2014-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rumination

Keywords

Rumination

Brief summary

Rumination is an upper gastrointestinal (GI) disorder characterized by the frequent regurgitation of recently ingested food. Very little is understood about the nature and treatment of this disorder. The act of regurgitation in rumination involves the opening of the upper esophageal sphincter and the muscular contraction of the abdomins rectus. Behavioral treatment of these symptoms is the clinical intervention of choice; however, only uncontrolled case documentation exists to support its effectiveness. However, an effective behavioral mechanism may be relaxation of the muscles. From a behavioral standpoint, muscular relaxation is incompatible with the necessary muscular contraction for rumination. To date, single case documentation and few designed single case studies have examined the clinical effectiveness of behavioral interventions for GI rumination. In the current study, the investigators seek to examine the effectiveness of two behavioral relaxation interventions for GI rumination through a treatment as usual paradigm (proposed N = 20). Our primary goals are to examine the clinical effectiveness of these interventions in symptom reduction at 1- and 3-month follow-up.

Interventions

BEHAVIORALDiaphragmatic breathing

Patients in this arm will be provided training in diaphragmatic breathing, taught its application in habit-reversal paradigm (to use after eating food and if urge to ruminate).

BEHAVIORALMuscle relaxation

Progressive passive muscle relaxation

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. At least 18 years of age. 2. Diagnosis of rumination by RomeIII criteria

Exclusion criteria

1. Active alcohol or substance abuse 2. Presence of a depressive disorder as measured by PHQ-9 score of 10 or above 3. Presence of clinical significant anxiety disorder as measured by GAD-7 score of 10 or above. 4. Severe levels of health focused anxiety as measured by SHAI score of 26 or above. 5. Any medical, neurological, or psychiatric condition that would impair the ability to consent and carry out all study procedures. 6. Any active psychosis or suicidality.

Design outcomes

Primary

MeasureTime frameDescription
Rumination Frequency assessed using Rome III Criteria1 month after interventionStudy participants will be treated with diaphragmatic breathing in one arm and muscle relaxation in the other arm. Outcome measure is: Rome III Study Questions Q8: In the last week, how often did food come back up into your mouth? Q10: When food came back up into your mouth, did it usually stay in your mouth for a while before you swallowed it or spit it out?
Rumination frequency assessed using Rome III Criteria3 months after interventionStudy participants will be treated with diaphragmatic breathing in one arm and muscle relaxation in the other arm. Outcome measure is: Rome III Study Questions Q8: In the last week, how often did food come back up into your mouth? Q10: When food came back up into your mouth, did it usually stay in your mouth for a while before you swallowed it or spit it out?

Secondary

MeasureTime frameDescription
Heath Care Utilization1 month after interventionHow many healthcare visits would you estimate were related to rumination since you started the intervention?
Short Health Anxiety Inventory (SHAI)1 month post interventionMeasure of degree to which intervention has impacted health concerns/anxiety. The SHAI is a validated measure
Sheehan Disability Scale (SDS)1 month after interventionThis is a measure of the impact of symptoms on Work, Family, and Social life. Uses a 10 point scale --with categories of mild,moderate severe
Treatment adherence1 month after interventionFollowing question will be posed: Did you engage in the intervention as you were instructed at your training session? The responses will be categorized for themes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026